Skip to content
Axcess News – Lifestyle
Author:
Vivos Therapeutics, Inc
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
June 11, 2026
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
June 10, 2026
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026
June 8, 2026
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing
June 5, 2026
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
April 7, 2026
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved ‘In-Network’ Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market
March 26, 2026
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
March 17, 2026